Genentech is a biotechnology company that specializes in the discovery, development, manufacturing, and commercialization of pharmaceutical drugs.
The company was founded in 1976 and is based in South San Francisco, California.
It is a subsidiary of the Swiss multinational healthcare company, Roche.
Genentech revolutionized the biotech and pharmaceutical industry by creating the first genetically engineered human insulin in 1978, which was a major breakthrough in the treatment of diabetes.
The company also developed the first monoclonal antibody, which is now used to target cancer cells in cancer treatment.
Genentech has developed several life-saving drugs used to treat a wide range of medical conditions, including cancer, multiple sclerosis, and a rare genetic disease called spinal muscular atrophy.
With more than 14,000 employees worldwide, Genentech continues to lead the industry in innovation and development of new therapies to improve patient outcomes.